Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO10092 | Hesperocyparis bakeri | Species | Cupressaceae | Eukaryota | UNPD* | |||
NPO10135 | Tripteris microcarpa | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO1017 | Dendrobium gibsonii | Species | Orchidaceae | Eukaryota | UNPD* | |||
NPO10513 | Lupinus pilosus | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO10994 | Sargentodoxa cuneata | Species | Lardizabalaceae | Eukaryota | TM-MC* | |||
NPO11066 | Fabiana imbricata | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO11411 | Gossypium herbaceum | Species | Malvaceae | Eukaryota | TCMID* | |||
NPO11411 | Gossypium herbaceum | Species | Malvaceae | Eukaryota | HerDing* | |||
NPO11597 | Stellaria dichotoma | Species | Caryophyllaceae | Eukaryota |
PMID[15387643] |
|||
NPO11786 | Cylindropuntia leptocaulis | Species | Cactaceae | Eukaryota | UNPD* |
Activity Type | # Activity |
---|---|
IC50 | 3 |
Others | 9 |
Potency | 5 |
Activity Type | # Activity |
---|---|
Cell Line | 3 |
Individual Protein | 2 |
Organism | 2 |
Others | 10 |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 25929 | nM | PubChem BioAssay data set | |
NPT1017 | Organism | Cricetinae gen. sp. | Cricetinae gen. sp. | Inhibition | = | 59 | % | 12639551 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | -19.8 | % | 11374953 |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 1090000 | nM | 19523836 | |
NPT2 | Others | Unspecified | IC50 | = | 61000000 | nM | 19523836 | |
NPT2 | Others | Unspecified | Inhibition | = | 16.8 | % | 20189399 | |
NPT2 | Others | Unspecified | Inhibition | = | 17.5 | % | 20189399 | |
NPT2 | Others | Unspecified | Inhibition | = | 18.9 | % | 20189399 | |
NPT2 | Others | Unspecified | Inhibition | = | 20.2 | % | 20189399 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
● The left chart: Distribution of similarity level between NPC32163 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).
range | Tanimoto Coefficient |
---|---|
0-0.1 | 206 |
0.1-0.2 | 1266 |
0.2-0.3 | 2866 |
0.3-0.4 | 7487 |
0.4-0.5 | 5298 |
0.5-0.6 | 2581 |
0.6-0.7 | 6029 |
0.7-0.8 | 4579 |
0.8-0.85 | 443 |
0.85-0.9 | 101 |
0.9-0.95 | 29 |
0.95-1 | 4 |
Similarity Score | Similarity Level | Natural Product ID |
---|
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
● The left chart: Distribution of similarity level between NPC32163 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range | Tanimoto Coefficient |
---|---|
0-0.1 | 248 |
0.1-0.2 | 986 |
0.2-0.3 | 1507 |
0.3-0.4 | 2560 |
0.4-0.5 | 1921 |
0.5-0.6 | 1217 |
0.6-0.7 | 577 |
0.7-0.8 | 135 |
0.8-0.85 | 7 |
0.85-0.9 | 2 |
0.9-0.95 | 0 |
0.95-1 | 1 |
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|
PubChem CID | 2214 |
ChEMBL | CHEMBL346919 |
ZINC |
Molecular Weight: | 166.06 |
ALogP: | -0.766 |
MLogP: | 2.12 |
XLogP: | 0.891 |
# Rotatable Bonds: | 5 |
Polar Surface Area: | 46.53 |
# H-Bond Aceptor: | 1 |
# H-Bond Donor: | 1 |
# Rings: | 1 |
# Heavy Atoms: | 12 |